We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

54 hedge funds and large institutions have $120M invested in Intersect ENT, Inc in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

20% more capital invested

Capital invested by funds: $100M → $120M (+$20.3M)

8% more funds holding

Funds holding: 50 → 54 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
54
Holders Change
+4
Holders Change %
+8%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
21
Reduced
13
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$3.41M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.6M
3
Morgan Stanley
Morgan Stanley
New York
+$2.28M
4
UOC
UBS O'Connor
Illinois
+$1.09M
5
Northern Trust
Northern Trust
Illinois
+$819K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.65M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.21M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.33M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.34M
5
Millennium Management
Millennium Management
New York
-$791K
Name Holding Trade Value Shares
Change 		Change in
Stake
NVPX
1
Norwest Venture Partners XI
California
$20.9M – – –
Wellington Management Group
2
Wellington Management Group
Massachusetts
$15M -$4.65M -258,677 -24%
Wells Fargo
3
Wells Fargo
California
$10.6M +$3.41M +189,599 +50%
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$6.6M +$44.3K +2,463 +0.7%
AC
5
Aisling Capital
New York
$6.49M – – –
NHAS
6
Novo Holdings A/S
Denmark
$6.49M – – –
RA
7
Royce & Associates
New York
$6.03M – – –
Millennium Management
8
Millennium Management
New York
$5.6M -$791K -43,963 -13%
Federated Hermes
9
Federated Hermes
Pennsylvania
$4.97M -$124K -6,900 -3%
WSA
10
Wall Street Associates
California
$3.66M – – –
Morgan Stanley
11
Morgan Stanley
New York
$3.26M +$2.28M +126,791 +259%
Vanguard Group
12
Vanguard Group
Pennsylvania
$3.17M +$2.6M +144,711 +554%
BFA
13
BlackRock Fund Advisors
California
$2.97M +$291K +16,154 +11%
KCM
14
Kornitzer Capital Management
Kansas
$2.54M -$54K -3,000 -2%
FCM
15
Frontier Capital Management
Massachusetts
$1.91M -$63.7K -3,538 -3%
BAMCO Inc
16
BAMCO Inc
New York
$1.83M +$378K +21,008 +27%
GPCM
17
Granite Point Capital Management
Massachusetts
$1.67M -$180K -10,000 -10%
Northern Trust
18
Northern Trust
Illinois
$1.47M +$819K +45,537 +136%
Allianz Asset Management
19
Allianz Asset Management
Germany
$1.39M +$405K +22,522 +43%
UOC
20
UBS O'Connor
Illinois
$1.13M +$1.09M +60,759 New
Ameriprise
21
Ameriprise
Minnesota
$1.1M +$383K +21,305 +56%
GGHC
22
Gilder Gagnon Howe & Co
New York
$1.1M +$811K +45,055 +319%
State Street
23
State Street
Massachusetts
$958K +$166K +9,200 +22%
BIT
24
BlackRock Institutional Trust
California
$951K -$9.54K -530 -1%
Goldman Sachs
25
Goldman Sachs
New York
$774K -$125K -6,971 -14%
1
2 3

XENT Hedge Fund Activity: Q4 2014 in Review

54 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2014, worth a combined $120M — up 20% from $100M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new XENT positions and 7 closed out — a net gain of 5 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Wells Fargo, adding an estimated $3.41M. The largest seller was Wellington Management Group, cutting an estimated $4.65M.

  • 54 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2014, up from 50 in Q3 2014.
  • Funds reported $120M of Intersect ENT, Inc stock for Q4 2014, up 20% quarter-over-quarter.
  • 12 funds opened new Intersect ENT, Inc positions in Q4 2014 and 7 closed out, a net change of +5 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2014 was Wells Fargo, an estimated $3.41M added.
  • The largest Intersect ENT, Inc seller in Q4 2014 was Wellington Management Group, an estimated $4.65M sold.

Based on aggregated 13F filings for Q4 2014.